Sage Therapeutics, Inc.

SAGEDelisted Jul 31, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001597553

SEC filings (opens in a new tab)

Sage Therapeutics, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Jul 31, 2025; 192 institutions reported holding it in 13F filings for Q2 2025, worth $445.6M in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Sage Therapeutics, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of SAGE: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Of which not filed for Q2 2023	Q2 2023	Change
Holders	214	1	225	+12
Shares	52.9M	8.27K	54.1M	+1.24M (+2.3%)
Value	$2.22B	$347.1K	$2.54B	+$321.8M (+14.5%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Sage Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to SAGE in Q2 2023
Institution	Shares	Value	% of portfolio
Casdin Capital, LLC	90,000	$4.23M	0.37%
Arrowstreet Capital, Limited Partnership	85,073	$4.00M	0.00%
Readystate Asset Management LP	82,568	$3.88M	0.38%
Qube Research & Technologies Ltd	77,924	$3.66M	0.01%
Empowered Funds, LLC	57,153	$2.69M	0.09%
EA Series Trust	57,153	$2.69M	0.09%
Walleye Capital LLC	54,561	$2.57M	0.05%
Edgestream Partners, L.P.	27,349	$1.29M	0.12%
Harbor Capital Advisors, Inc.	21,053	$989.9K	0.20%
EFG Asset Management (North America) Corp.	21,003	$987.2K	0.21%
Schonfeld Strategic Advisors LLC	20,823	$979.1K	0.01%
Essex Investment Management Co LLC	20,360	$957.3K	0.13%
International Biotechnology Trust PLC	20,000	$939.4K	0.29%
Engineers Gate Manager LP	19,340	$909.4K	0.03%
Virtu Financial LLC	17,793	$837.0K	0.06%
Oppenheimer & Co Inc	14,813	$696.5K	0.01%
Neo Ivy Capital Management	10,290	$484.0K	0.26%
Cavalier Investments, LLC	9,679	$455.1K	0.17%
Fox Run Management, L.L.C.	9,606	$451.7K	0.13%
Y-Intercept (Hong Kong) Ltd	8,774	$412.6K	0.04%
STRS Ohio	7,300	$343.0K	0.00%
Walleye Trading LLC	5,721	$269.0K	0.01%
Aquatic Capital Management LLC	5,600	$263.0K	0.01%
Commonwealth Equity Services, LLC	5,121	$241.0K	0.00%
Simplex Trading, LLC	2,562	$120.0K	0.01%
Headlands Technologies LLC	2,442	$114.8K	0.04%
Hanseatic Management Services Inc	715	$34.0K	0.06%
Umb Bank N A	19	$893	0.00%
Versant Capital Management, Inc	15	$705	0.00%
ORG Partners LLC	5	$241	0.00%

Sold out (18)

Institutions that held Sage Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of SAGE in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Thrivent Financial for Lutherans	30,567	$1.28M
Healthcare of Ontario Pension Plan Trust Fund	25,000	$1.05M
Banque Pictet & Cie SA	20,223	$848.6K
Winton Group Ltd	19,356	$812.2K
Ikarian Capital, LLC	17,805	$747.1K
Axq Capital, LP	14,412	$604.7K
Algert Global LLC	14,280	$599.2K
Marex Group plc	10,814	$453.8K
Gsa Capital Partners LLP	10,721	$450.0K
Shay Capital LLC	6,000	$251.8K
Quantamental Technologies LLC	5,653	$237.2K
Cornercap Investment Counsel Inc	4,984	$209.1K
TCI Wealth Advisors, Inc.	320	$13.4K
Crewe Advisors LLC	55	$2.31K
Schubert & Co	31	$1.30K
Northwestern Mutual Wealth Management Co	10	$420
Values First Advisors, Inc.	1	$40
Steward Financial Group LLC	23	$0

Not filed for Q2 2023 yet (1)

Institutions that held Sage Therapeutics, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SAGE in Q1 2023 that haven't filed for Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Kula Investments, LLC	8,273	$347.1K